AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17725758 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 40
Study 15001195 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily) + diet
Number of subjects: 120
Study 15001195 — intervention group
Group type: COMPARATOR
Intervention: Placebo + diet
Number of subjects: 120
Study 11145795 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment
Number of subjects: 351
Study 11145795 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 351
Study 11145795 — intervention group
Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 351
Study 9695299 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms, twice a day for 3 weeks)
Number of subjects: 43
Study 9695299 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (2 mg, twice a day for 3 weeks)
Number of subjects: 43
Study 9695299 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (25 micrograms, twice a day for 3 weeks)
Number of subjects: 43
Study 9695299 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice a day for 3 weeks)
Number of subjects: 43
Study 7912042 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐adrenergic blocker
Number of subjects: 34
Study 7912042 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study 7912042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 2809777 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-g carbohydrate meal
Number of subjects: 66
Study 2809777 — intervention group
Group type: COMPARATOR
Intervention: 50-g glucose load (Glucola)
Number of subjects: 66
Study 2809777 — intervention group
Group type: COMPARATOR
Intervention: Glucola
Number of subjects: 66
Study 342621 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated whole influenza A/New Jersey/8/76 virus vaccine (graded doses of 4-61 micrograms of hemagglutinin)
Number of subjects: 0
Study 342621 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent vaccine (A/New Jersey/76, A/Victoria/75, B/Hong Kong/73)
Number of subjects: 0
Study 342621 — intervention group
Group type: COMPARATOR
Intervention: 61-microgram dose of hemagglutinin
Number of subjects: 0
Study 30556428 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media parenting intervention (Facebook)
Number of subjects: 24
Study 30556428 — intervention group
Group type: COMPARATOR
Intervention: In-person parenting intervention
Number of subjects: 24
Study 28800090 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (1680 mg)
Number of subjects: 32
Study 28800090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 25990482 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mcg misoprostol sublingually
Number of subjects: 500
Study 25990482 — intervention group
Group type: COMPARATOR
Intervention: 10 units oxytocin intramuscularly
Number of subjects: 500
Study 23353175 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopic varicocelectomy (group A, n=130)
Number of subjects: 260
Study 23353175 — intervention group
Group type: COMPARATOR
Intervention: Conventional Palomo varicocelectomy (group B, n=130)
Number of subjects: 260
Study 21321030 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (shared reading activities modeled by nurses, supported by parent information and free books)
Number of subjects: 552
Study 19595145 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprenone (intervention group, n=45)
Number of subjects: 92
Study 19595145 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=47)
Number of subjects: 92
Study 17012719 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion followed by acid etching (Group II)
Number of subjects: 16
Study 17012719 — intervention group
Group type: COMPARATOR
Intervention: Acid etching (Group I)
Number of subjects: 16
Study 12753338 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced group (n = 114) received IFN-2b 6 million units (MU) thrice weekly (TIW) and ribavirin for 48 weeks
Number of subjects: 231
Study 12753338 — intervention group
Group type: COMPARATOR
Intervention: Nonreinforced group (n = 117) received IFN-2b 3 MU TIW and ribavirin for 24 weeks
Number of subjects: 231
Study 12753338 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced group (n = 80)
Number of subjects: 231
Study 12753338 — intervention group
Group type: COMPARATOR
Intervention: Nonreinforced group (n = 80)
Number of subjects: 231
Study 11023017 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Skills Training (cognitive-behavioral skills-training prevention program) during junior high school
Number of subjects: 447
Study 11023017 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 447
Study 9354208 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg isosorbide dinitrate b.d.
Number of subjects: 12
Study 9354208 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg isosorbide dinitrate b.d.
Number of subjects: 12
Study 9354208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8371915 — intervention group
Group type: EXPERIMENTAL
Intervention: PhXA41 (0.006%)
Number of subjects: 22
Study 8371915 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 22
Study 2873440 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled platelet activating factor (PAF)
Number of subjects: 8
Study 2873440 — intervention group
Group type: COMPARATOR
Intervention: Lyso‐PAF (inactive precursor of PAF)
Number of subjects: 8
Study 31802559 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (1,500 mg/day)
Number of subjects: 70
Study 31802559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 29760009 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based behavioural intervention to reduce formula milk intake
Number of subjects: 669
Study 29760009 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 669
Study 26812574 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 70
Study 26812574 — intervention group
Group type: COMPARATOR
Intervention: Brain Health Workshop (BHW) (Control)
Number of subjects: 70
Study 24865129 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifluorid 12 two applications/year
Number of subjects: 1365
Study 24865129 — intervention group
Group type: EXPERIMENTAL
Intervention: Duraphat two applications/year
Number of subjects: 1365
Study 24865129 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifluorid 12 four applications/year
Number of subjects: 1365
Study 24865129 — intervention group
Group type: COMPARATOR
Intervention: No fluoride varnish at school (Control)
Number of subjects: 1365
Study 22665144 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy isoflavone supplementation (25 g of isoflavone-rich soy protein daily)
Number of subjects: 313
Study 22665144 — intervention group
Group type: COMPARATOR
Intervention: Milk protein-matched placebo
Number of subjects: 313
Study 22665144 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy isoflavone supplementation
Number of subjects: 313
Study 20438830 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac exposure
Number of subjects: 145
Study 20438830 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-teratogenic agents)
Number of subjects: 145
Study 17627707 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoprocaf
Number of subjects: 297
Study 17627707 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan
Number of subjects: 297
Study 15735614 — intervention group
Group type: EXPERIMENTAL
Intervention: BIBN4096BS (2.5 mg)
Number of subjects: 10
Study 15735614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12853500 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (42 microg bid)
Number of subjects: 45
Study 12853500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 12853500 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TAA), 400 microg bid
Number of subjects: 45
Study 12853500 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol or Placebo after the run-in
Number of subjects: 45
Study 10912141 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-oriented care (B2)
Number of subjects: 1010
Study 10912141 — intervention group
Group type: COMPARATOR
Intervention: Routine care (A1, B1)
Number of subjects: 1010
Study 8643858 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (50 mg/day) starting from the 6th irradiation session throughout the treatment
Number of subjects: 80
Study 8643858 — intervention group
Group type: COMPARATOR
Intervention: Control group (baseline treatment only, fluconazole given only when mycotic infections appeared)
Number of subjects: 80
Study 1353996 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (CTZ) 10 mg single dose
Number of subjects: 0
Study 1353996 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine (TER) 60 mg single dose
Number of subjects: 0
Study 1353996 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (CTZ) 10 mg once a day for 3 weeks
Number of subjects: 0
Study 1353996 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine (TER) 60 mg b.i.d. for 3 weeks
Number of subjects: 0
Study 6407047 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl citrate (0.1 mg)
Number of subjects: 0
Study 6407047 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (1.2 or 0.4 mg)
Number of subjects: 0
Study 6407047 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (double-blind)
Number of subjects: 0
Study 6407047 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl citrate (0.1 mg) without reversal injection
Number of subjects: 0
Study 31254340 — intervention group
Group type: EXPERIMENTAL
Intervention: Practitioner-facilitated personalized nutrition intervention (n=36)
Number of subjects: 55
Study 31254340 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition-based gene test report (control; n=19)
Number of subjects: 55
Study 28957983 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy intervention (modified constraint-induced movement therapy) for 3 hours for 10 consecutive days
Number of subjects: 36
Study 28957983 — intervention group
Group type: COMPARATOR
Intervention: Individual modified constraint-induced movement therapy for 3 hours for 10 consecutive days
Number of subjects: 36
Study 27156611 — intervention group
Group type: EXPERIMENTAL
Intervention: RHZEL (RHZE + levofloxacin)
Number of subjects: 57
Study 27156611 — intervention group
Group type: COMPARATOR
Intervention: RHZE (rifampicin, isoniazid, pyrazinamide and ethambutol)
Number of subjects: 57
Study 25099160 — intervention group
Group type: EXPERIMENTAL
Intervention: Work Productivity Survey (WPS)
Number of subjects: 0
Study 23031428 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-layer bandage (4LB)
Number of subjects: 424
Study 23031428 — intervention group
Group type: COMPARATOR
Intervention: Short-stretch bandage (SSB)
Number of subjects: 424
Study 20590736 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg once daily
Number of subjects: 319
Study 20590736 — intervention group
Group type: COMPARATOR
Intervention: Voglibose 0.2 mg thrice daily
Number of subjects: 319
Study 18001608 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter and prescription medications (oral, topical, or injectable routes)
Number of subjects: 0
Study 16270633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.0 mg/kg b.i.d on two days
Number of subjects: 9
Study 16270633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0, 0.01, 1 microM) in cultured human umbilical endothelial cells
Number of subjects: 9
Study 14589465 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal electrothermal anuloplasty (IDETA)
Number of subjects: 53
Study 14589465 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 53
Study 10635302 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (UFT 300‐450 mg/day, 5 days a week and 5‐FU 440‐600 mg/m2/24 hr once a week)
Number of subjects: 22
Study 10635302 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (UFT less than 300 mg/day, 5 days a week, and/or 5‐FU less than 440 mg/m2/24 hr once a week)
Number of subjects: 22
Study 10635302 — intervention group
Group type: COMPARATOR
Intervention: Control Group C (non‐PMC cases matched for other background factors)
Number of subjects: 22
Study 7772361 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg intravenous (i.v.) ondansetron
Number of subjects: 57
Study 7772361 — intervention group
Group type: COMPARATOR
Intervention: 0.075 mg/kg i.v. droperidol
Number of subjects: 57
Study 2373131 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR 50 mg
Number of subjects: 20
Study 2373131 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR 100 mg
Number of subjects: 20
Study 2373131 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 20
Study 2373131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7380750 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session interpersonal skills training program including instruction in Introduction and Small Talk, Asking for Help, Differing with Others, and Handling Criticism.
Number of subjects: 16
Study 7380750 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session interpersonal skills training program
Number of subjects: 16
Study 30762400 — intervention group
Group type: EXPERIMENTAL
Intervention: Biobehavioral intervention (BBI)
Number of subjects: 160
Study 30762400 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (Control)
Number of subjects: 160
Study 29374961 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application lifestyle modification (app user group)
Number of subjects: 47
Study 29374961 — intervention group
Group type: COMPARATOR
Intervention: Usual practice lifestyle modification (control group)
Number of subjects: 47
Study 29374961 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (app user and control)
Number of subjects: 47
Study 27529274 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched-β-Conglycinin Soybean (Nanahomare)
Number of subjects: 134
Study 27529274 — intervention group
Group type: COMPARATOR
Intervention: Low-β-Conglycinin Soybean (Placebo)
Number of subjects: 134
Study 24766179 — intervention group
Group type: EXPERIMENTAL
Intervention: Group diabetes education led by health promoters (4 monthly sessions)
Number of subjects: 1570
Study 24766179 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1570
Study 22673961 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartCode™ Basic Life Support (BLS)
Number of subjects: 606
Study 22673961 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-led (IL) course
Number of subjects: 606
Study 22673961 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly practice of CPR skills
Number of subjects: 606
Study 22673961 — intervention group
Group type: COMPARATOR
Intervention: No further practice
Number of subjects: 606
Study 22673961 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial course type (HeartCode™ BLS vs IL)
Number of subjects: 606
Study 19193417 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin daily
Number of subjects: 102
Study 19193417 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg alfuzosin daily
Number of subjects: 102
Study 19193417 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 102
Study 17261462 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive educational/behavioral/pharmacologic intervention
Number of subjects: 309
Study 17261462 — intervention group
Group type: COMPARATOR
Intervention: Less intensive information and referral intervention
Number of subjects: 309
Study 15068150 — intervention group
Group type: EXPERIMENTAL
Intervention: Checker game moves (1 to 4 steps)
Number of subjects: 28
Study 11676358 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime diuretic therapy (azosemide 60 mg)
Number of subjects: 51
Study 11676358 — intervention group
Group type: COMPARATOR
Intervention: Minor tranquilizer
Number of subjects: 51
Study 9559686 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 100
Study 9559686 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy
Number of subjects: 100
Study 9559686 — intervention group
Group type: COMPARATOR
Intervention: Salvage operations (radiotherapy)
Number of subjects: 100
Study 9559686 — intervention group
Group type: COMPARATOR
Intervention: Salvage operations (chemoradiotherapy)
Number of subjects: 100
Study 9559686 — intervention group
Group type: COMPARATOR
Intervention: Planned neck dissections (radiotherapy)
Number of subjects: 100
Study 9559686 — intervention group
Group type: COMPARATOR
Intervention: Planned neck dissections (chemoradiotherapy)
Number of subjects: 100
Study 8178408 — intervention group
Group type: EXPERIMENTAL
Intervention: KLH (1 mg intracutaneously, followed by 30 mg weekly for 6 weeks and then monthly for 1 year)
Number of subjects: 161
Study 8178408 — intervention group
Group type: COMPARATOR
Intervention: etoglucid (0.565 g weekly for 6 weeks and then monthly for 1 year)
Number of subjects: 161
Study 2959425 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 50
Study 2959425 — intervention group
Group type: EXPERIMENTAL
Intervention: diltiazem
Number of subjects: 50
Study 2959425 — intervention group
Group type: EXPERIMENTAL
Intervention: nicardipine
Number of subjects: 50
Study 2959425 — intervention group
Group type: EXPERIMENTAL
Intervention: nisoldipine
Number of subjects: 50
Study 2959425 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine
Number of subjects: 50
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: A. annua tea infusion (1l/d of dry leaf/twig tea infusions divided into 3 aliquots daily for 7 days)
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: A. afra tea infusion (1l/d of dry leaf/twig tea infusions divided into 3 aliquots daily for 7 days)
Number of subjects: 800
Study 30466622 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel (PZQ) treatment (followed manufacturer posology)
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms (A. annua, A. afra, PZQ)
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: PZQ and A. afra treatment
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: PZQ and A. annua treatment
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: A. afra treatment in males
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: PZQ and A. afra treatment in females
Number of subjects: 800
Study 30466622 — intervention group
Group type: EXPERIMENTAL
Intervention: A. annua treatment
Number of subjects: 800
Study 27858689 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS+Exercise
Number of subjects: 69
Study 27858689 — intervention group
Group type: EXPERIMENTAL
Intervention: KT+Exercise
Number of subjects: 69
Study 27858689 — intervention group
Group type: COMPARATOR
Intervention: Exercise (Control)
Number of subjects: 69
Study 26424105 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 414
Study 26424105 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus the HFM website
Number of subjects: 414
Study 26424105 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted care pathway with an interactive platform (e-Vita platform)
Number of subjects: 414
Study 23036856 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (360 minutes/week)
Number of subjects: 202
Study 22037175 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 38
Study 22037175 — intervention group
Group type: COMPARATOR
Intervention: Pulsed magnetic field (PMF)
Number of subjects: 38
Study 18299094 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene block with catheter installation
Number of subjects: 60
Study 18299094 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular local anesthetic with catheter installation
Number of subjects: 60
Study 12593999 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined rosiglitazone and clomiphene citrate
Number of subjects: 50
Study 12593999 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate monotherapy
Number of subjects: 50
Study 10330960 — intervention group
Group type: EXPERIMENTAL
Intervention: Antilymphocyte antibody induction therapy
Number of subjects: 0
Study 10330960 — intervention group
Group type: COMPARATOR
Intervention: Induction therapy with cyclosporine, azathioprine, and prednisone
Number of subjects: 0
Study 8675969 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 19
Study 8675969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 2205078 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid treatment
Number of subjects: 74
Study 2205078 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 74
Study 75438 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg and cows' milk exclusion diet (soya-based milk substitute)
Number of subjects: 20
Study 75438 — intervention group
Group type: COMPARATOR
Intervention: Control diet (egg and cows' milk preparation)
Number of subjects: 20
Study 75438 — intervention group
Group type: EXPERIMENTAL
Intervention: First diet period (egg and cows' milk exclusion diet)
Number of subjects: 20
Study 75438 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial diet (egg and cows' milk exclusion diet)
Number of subjects: 20
Study 30710602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mohs micrographic surgery (MMS)
Number of subjects: 256
Study 30710602 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical excision
Number of subjects: 256
Study 28942094 — intervention group
Group type: EXPERIMENTAL
Intervention: MAT9001 (4 g/d)
Number of subjects: 0
Study 28942094 — intervention group
Group type: COMPARATOR
Intervention: EPA-EE (4 g/d)
Number of subjects: 0
Study 25043197 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon lambda-1a (Lambda) 120 μg
Number of subjects: 0